Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-1,800
Closed -$52K – 7484
2020
Q3
$52K Sell
1,800
-1,400
-44% -$44K ﹤0.01% 5575
2020
Q2
$114K Buy
3,200
+3,100
+3,100% +$131K ﹤0.01% 5473
2020
Q1
$5K Sell
100
-100
-50% -$4.8K ﹤0.01% 7266
2019
Q4
$14K Sell
200
-2,900
-94% -$182K ﹤0.01% 7084
2019
Q3
$149K Sell
3,100
-12,000
-79% -$626K ﹤0.01% 5386
2019
Q2
$1.01M Sell
15,100
-1,500
-9% -$114K ﹤0.01% 3621
2019
Q1
$1.58M Buy
16,600
+9,600
+137% +$1.2M ﹤0.01% 2917
2018
Q4
$869K Buy
7,000
+5,100
+268% +$840K ﹤0.01% 3542
2018
Q3
$464K Buy
+1,900
New +$439K ﹤0.01% 4375

Other funds holding INGN

Citigroup's INGN Position: Q3 2026 in Review

Citigroup reduced its Inogen (INGN) stake by 89% in Q3 2026, selling an estimated $60K and leaving 1,211 shares worth $6.38K. The position accounts for ﹤0.01% of the portfolio, ranked #5308.

Citigroup first reported a position in INGN in Q1 2014 and has held it in 51 quarters since. The position peaked at $4.66M in Q2 2019. 98 funds tracked by Wall St. Rank hold INGN as of Q3 2026.

  • Citigroup held 1,211 shares of Inogen worth $6.38K as of Q3 2026.
  • Citigroup sold 10,211 Inogen shares in Q3 2026, an estimated $60K.
  • Inogen made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5308 holding.
  • Citigroup first reported a position in Inogen in Q1 2014 and has held it in 51 quarters since.
  • Citigroup's Inogen position peaked at $4.66M in Q2 2019.
  • 98 funds tracked by Wall St. Rank held Inogen as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.